Trial document



drksid header

  DRKS00012931

Trial Description

start of 1:1-Block title

Title

Hypogeusia In Vim/DRT-DBS

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

HIDDen

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Essential tremor can be treated with Deep Brain Stimulation (DBS), if it does not respond to medication anymore. Leading symptom of essenital tremor is a disturbing trembling of hands. This leads to decreased quality of life, as it interferes for example with eating and drinking, dressing etc.
For DBS therapy electrodes are implanted into a certain region in the brain. Stimulation of this region may lead to improvement of tremor symptoms.
As a side effect, taste disturbances can occur under DBS for essential tremor (and other tremor diseases). Upon deactivation of the stimulation these taste disturbances disappear and therefor these taste disturbances are stimulation-induced. Stimulation-induced taste disturbances are a dilemma, as the stimulation reduces the stigma of tremor patients, so they dare to eat and drink in public again but with an impaired sense of taste. This study aims at determining the cause, frequency and risk-factors of stimulation-induced taste disturbances under DBS for essential tremor. Participating patients will undergo tests of smelling and tasting before and after implantation of the DBS-system. Tremor patients with a planned DBS implantation for tremor in our department can take part in the study.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

This is a prospective interventional study examining the cause and frequency of stimulation-induced hypogeusia under thalamic deep brain stimulation (DBS) for tremor. We postulate that stimulation-induced hypogeusia is related to the distance between the volume of activated tissue and the course of the gustatory tract. Participating patients will undergo rhinomanometry, gustometry and olfactometry before and 6-12 months after DBS-implantation. The location of the volume of activated tissue in relation to the gustatory tract will be determined using the stimulation parameters and routine perioperative imaging. The operation itself is not part of the study and will only be performed in patients meeting clinical criteria for indication according to accepted guidelines.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?

[---]*

end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:

[---]*

end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00012931
  •   2017/09/08
  •   [---]*
  •   yes
  •   Approved
  •   284/17, Ethik-Kommission der Albert-Ludwigs-Universität Freiburg
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   G25.0 -  Essential tremor
  •   R43.8 -  Other and unspecified disturbances of smell and taste
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Pre-operative gustometry, olfactometry and rhinomanometry prior to implantation of DBS (Deep Brain Stimulation) system. Post-operative gustometry, olfactometry and rhinomanometry 6-12 months after implantation. When post-operative results differ from pre-operative test results gustometry, olfactometry and rhinomanometry will be repeated with DBS stimulator turned OFF.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Interventional
  •   [---]*
  •   Single arm study
  •   Open (masking not used)
  •   [---]*
  •   Uncontrolled/Single arm
  •   Diagnostic
  •   Single (group)
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

To compare gustatory and olfactory function by means of olfactometry and gustometry preoperatively as well as 6-12 months after Implantation of DBS (Deep Brain Stimulation)

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Identification of risk factors for stimulation-induced hypogeusia (age, sex, pre-existing disturbance of olfaction or gustation).

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2017/10/18
  •   30
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

1. Adult tremor patients who are being treated with DBS and where DTI imaging data is available. Decision for DBS therapy is made according to standard guidelines outside this study.
2. Written informed consent.

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

1. Patients suffering from multiple sclerosis.
2- Patients with allergies on citric acid or chinine.

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Universitätsklinikum FreiburgKlinik für NeurochirurgieAbteilung für Stereotaktische und Funktionelle Neurochirurgie
    • Mr.  Prof. Dr.  Volker  Coenen 
    • Breisacher Str. 64
    • 79104  Freiburg
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Universitätsklinikum FreibugKlinik für NeurochirurgieAbteilung für Stereotaktische und Funktionelle Neurochirurgie
    • Mr.  Dr.  Bastian  Sajonz 
    • Breisacher Str. 64
    • 79104  Freiburg
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Universitätsklinikum FreibugKlinik für NeurochirurgieAbteilung für Funktionelle und Stereotaktische Neurochirurgie
    • Mr.  Dr.  Bastian  Sajonz 
    • Breisacher Str. 64
    • 79104  Freiburg
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Universitätsklinikum FreibugKlinik für NeurochirurgieAbteilung für Funktionelle und Stereotaktische Neurochirurgie
    • Mr.  Dr.  Bastian  Sajonz 
    • Breisacher Str. 64
    • 79104  Freiburg
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting ongoing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.